Source comparison
CJC-1295 vs CJC-1295 No DAC: Full Comparison
Half-life 6–8 days (albumin-bound) 30 minutes (rapid renal clearance) DAC extends circulation; no DAC preserves natural clearance rate Dosing frequency Once weekly to biweekly 1–3 times daily Frequency reflects half-life. Sustained vs pulsatile exposure GH rel
This comparison does not assign a generated winner or score.
- Half-life
- 6–8 days (albumin-bound)
- 30 minutes (rapid renal clearance)
- DAC extends circulation; no DAC preserves natural clearance rate
- Dosing frequency
- Once weekly to biweekly
- 1–3 times daily
- Frequency reflects half-life. Sustained vs pulsatile exposure
- GH release pattern
- Sustained elevation over days
- Discrete pulse per injection (peaks 20–30 min)
- DAC creates non-physiological steady state; no DAC mimics endogenous pulses
- Typical dose
- 1–2 mg per injection
- 100–200 mcg per injection
- Dose scales inversely with frequency. Fewer injections require higher total peptide
- Common research use
- Long-term anabolic studies, tissue repair timelines
- Pulsatile GH dynamics, GHRH+GHRP synergy studies
- Use case drives selection. Duration vs rhythm
- Compatibility with GHRPs
- Limited (sustained GH may blunt GHRP amplification)
- High (short half-life preserves pulse amplitude synergy)
- Modified GRF amplifies GHRP-induced pulses; DAC version does not